The Board of Directors of BlackRock Health Sciences Trust II has authorized a buyback plan on September 8, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.58 USD | -0.75% | +0.48% | -0.48% |
2023 | Saba Capital Master Fund, Ltd Issues a Letter to BlackRock Health Sciences Term Trust | CI |
2023 | BlackRock Health Sciences Term Trust authorizes a Buyback Plan. | CI |
1st Jan change | Capi. | |
---|---|---|
-0.48% | 1.64B | |
+3.00% | 12.52B | |
+6.90% | 8.84B | |
-3.71% | 5.39B | |
+5.13% | 5.16B | |
-0.21% | 5.11B | |
+14.85% | 4.51B | |
+16.63% | 4.44B | |
+1.69% | 4.01B | |
+2.10% | 3.75B |
- Stock Market
- Equities
- BMEZ Stock
- News BlackRock Health Sciences Term Trust
- BlackRock Health Sciences Trust II authorizes a Buyback Plan.